American ginseng berry enhances chemopreventive effect of 5-FU on human colorectal cancer cells

Oncology Reports

Volumn 22, Issue 4, 2009, Pages 943-952

  Li, Xiao Li ^a,b   Wang, Chong Zhi ^a,b   Sun, Shi ^a,b   Mehendale, Sangeeta R ^a,b   Du, Wei ^b   He, Tong Chuan ^b   Yuan, Chun Su ^a,b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

American ginseng; Human colorectal can

Indexed keywords

AMERICAN GINSENG BERRY EXTRACT; CYCLIN A; FLUOROURACIL; GINSENG EXTRACT; GINSENOSIDE; GINSENOSIDE RB 1; GINSENOSIDE RB 2; GINSENOSIDE RC; GINSENOSIDE RD; GINSENOSIDE RE; GINSENOSIDE RG 1; GINSENOSIDE RG 3; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER COMBINATION CHEMOTHERAPY; CANCER INHIBITION; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELLULAR DISTRIBUTION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG POTENTIATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MONOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; DRUG SYNERGISM; FLUOROURACIL; FRUIT; HT29 CELLS; HUMANS; PANAX; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 70350370012     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000521     Document Type: Article

References (37)

1. Csejtei A, Tibold A, Varga Z, et al: GSTM, GSTT and p53 polymorphisms as modifiers of clinical outcome in colorectal cancer. Anticancer Res 28: 1917-1922, 2008.
2. Delval L and Klastersky J: Optic neuropathy in cancer patients. Report of a case possibly related to 5-fluorouracil toxicity and review of the literature. J Neurooncol 60: 165-169, 2002.
3. Viale PH and Yamamoto DS: Cardiovascular toxicity associated with cancer treatment. Clin J Oncol Nurs 12: 627-638, 2008.
4. Patel BB, Sengupta R, Qazi S, et al: Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in mediating growth inhibition of colon cancer cells by modulating EGFR and IGF-1R. Int J Cancer 122: 267-273, 2008.
5. Politano S, Overman M, Pathak P, et al: Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness. Clin Colorectal Cancer 7: 55-59, 2008.
6. Sheikh HY, Valle JW, Waddell T, et al: Alternating irinotecan with oxaliplatin combined with UFT plus leucovorin (SCOUT) in metastatic colorectal cancer. Br J Cancer 99: 577-583, 2008.
7. Kim YJ, Kang SA, Hong MS, et al: Coptidis rhizoma induces apoptosis in human colorectal cancer cells SNU-C4. Am J Chin Med 32: 873-882, 2004.
8. Luo JZ and Luo L: Ginseng on hyperglycemia: Effects and mechanisms. Evid Based Complement Alternat Med (In Press).
9. Vuksan V, Stavro MP, Sievenpiper JL, et al: American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation. J Am Coll Nutr 19: 738-744, 2000.
10. Duda RB, Zhong Y, Navas V, et al: American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth. J Surg Oncol 72: 230-239, 1999.
11. King ML and Murphy LL: American ginseng (Panax quinquefolius L.) extract alters mitogen-activated protein kinase cell signaling and inhibits proliferation of MCF-7 cells. J Exp Ther Oncol 6: 147-155, 2007.
12. Luo X, Wang CZ, Chen J, et al: Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol 32: 975-983, 2008.
13. Wang CZ and Yuan CS: Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 36: 1019-1028, 2008.
14. Wang CZ, Mehendale SR and Yuan CS: Commonly used antioxidant botanicals: active constituents and their potential role in cardiovascular illness. Am J Chin Med 35: 543-558, 2007.
15. Xie JT, McHendale S and Yuan CS: Ginseng and diabetes. Am J Chin Med 33: 397-404, 2005.
16. Wang CZ, Wu JA, McEntee E, et al: Saponins composition in American ginseng leaf and berry assayed by high-performance liquid chromatography. J Agric Food Chem 54: 2261-2266, 2006.
17. Attele AS, Zhou YP, Xie JT, et al: Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51: 1851-1858, 2002.
18. Xie JT, Aung HH, Wu JA, et al: Effects of American ginseng berry extract on blood glucose levels in ob/ob mice. Am J Chin Med 30: 187-194, 2002.
19. Xie JT, Wang CZ, Ni M, et al: American ginseng berry juice intake reduces blood glucose and body weight in ob/ob mice. J Food Sci 72: S590-S594, 2007.
20. Mehendale SR, Wang CZ, Shao ZH, et al: Chronic pretreatment with American ginseng berry and its polyphenolic constituents attenuate oxidant stress in cardiomyocytes. Eur J Pharmacol 553: 209-214, 2006.
21. Mehendale S, Aung H, Wang A, et al: American ginseng berry extract and ginsenoside Re attenuate cisplatin-induced kaolin intake in rats. Cancer Chemother Pharmacol 56: 63-69, 2005.
22. Aung HH, Mehendale SR, Wang CZ, et al: Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng. Cancer Chemother Pharmacol 59: 369-374, 2007.
23. Wang CZ, Zhang B, Song WX, et al: Steamed American ginseng berry: ginsenoside analyses and anticancer activities. J Agric Food Chem 54: 9936-9942, 2006.
24. Pinedo HM and Peters GF: Fluorouracil: biochemistry and pharmacology. J Clin Oncol 6: 1653-1664, 1988.
25. Smorenburg CH, Peters GJ, van Groeningen CJ, et al: Phase II study of tailored chemotherapy for advanced colorectal cancer with either 5-fluouracil and leucovorin or oxaliplatin and irinotecan based on the expression of thymidylate synthase and dihydropyrimidine dehydrogenase. Ann Oncol 17: 35-42, 2006.
26. Wolpin BM and Mayer RJ: Systemic treatment of colorectal cancer. Gastroenterology 134: 1296-1310, 2008.
27. Meregalli M, Martignoni G, Frontini L, et al: Increasing doses of 5-fluorouracil and high-dose folinic acid in the treatment of metastatic colorectal cancer. Tumori 84: 662-665, 1998.
28. Ang-Lee MK, Moss J and Yuan CS: Herbal medicines and perioperative care. JAMA 286: 208-216, 2001.
29. Ernst E: The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava. Ann Intern Med 136: 42-53, 2002.
30. Wang CZ, Li P, Ding JY, et al: Discrimination of Lonicera japonica THUNB. from different geographical origins using restriction fragment length polymorphism analysis. Biol Pharm Bull 30: 779-782, 2007.
31. Wang CZ, Li P, Ding JY, et al: Simultaneous identification of Bulbus Fritillariae cirrhosae using PCR-RFLP analysis. Phytomedicine 14: 628-632, 2007.
32. Assinewe VA, Baum BR, Gagnon D, et al: Phytochemistry of wild populations of Panax quinquefolius L. (North American ginseng). J Agric Food Chem 51: 4549-4553, 2003.
33. Reed JC and Pellecchia M: Apoptosis-based therapies for hematologic malignancies. Blood 106: 408-418, 2005.
34. Wu WY, Guo HZ, Qu GQ, et al: Mechanisms of pseudolaric Acid B-induced apoptosis in bel-7402 cell lines. Am J Chin Med 34: 887-899, 2006.
35. Moon PD, Koo HN, Jeong HJ, et al: Haeamtang induces apoptosis of colon cancer HT-29 cells through activation of caspase-3. Am J Chin Med 35: 897-909, 2007.
36. Nakayama KI and Nakayama K: Ubiquitin ligases: cell-cycle control and cancer. Nat Rev Cancer 6: 369-381, 2006.
37. Yoshikawa R, Kusunoki M, Yanagi H, et al: Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res 61: 1029-1037, 2001.